Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

Zoetis Inc. (NYSE: ZTS), the world's premier animal health company, has announced that its Chief Executive Officer, Kristin Peck, will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, at 10:30 a.m. ET. Interested stakeholders can access the live audio webcast of this event via Zoetis' investor relations page at https://investor.zoetis.com/events-presentations. Furthermore, a replay of the presentation will be made available on the company's website following the conclusion of the event.

With a legacy spanning nearly 75 years, Zoetis is dedicated to improving animal health worldwide. The company’s mission is to nurture the world and enhance human health by advancing care for animals. Operating in over 100 countries, Zoetis provides groundbreaking solutions for predicting, preventing, detecting, and treating animal illnesses. Its offerings include medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions, all driven by robust scientific expertise and data-informed research and development.

Zoetis aims to be the most trusted and valued company in the animal health sector. This commitment is reflected in its dedication to innovation, customer satisfaction, and the expertise of its purpose-driven workforce. By setting new standards for animal care, Zoetis continues to solidify its position as a leader in the field, integrating advanced manufacturing and commercial excellence to deliver meaningful innovations.

For media inquiries, Zoetis has designated contacts, such as Jennifer Albano at 1-862-399-0810 and Laura Panza at 1-973-975-5176. For investor-related questions, Steve Frank and Nick Soonthornchai are available for assistance. More information about Zoetis can be found on its website, Zoetis.com.

As Zoetis Inc. (NYSE: ZTS) prepares for its participation in the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, investor attention is keenly focused on the company's growth prospects and market positioning within the animal health sector. With a legacy spanning nearly 75 years, Zoetis has established itself as an industry leader, offering a comprehensive range of products and services aimed at improving animal health and well-being.

From a financial perspective, Zoetis has demonstrated a strong track record of revenue growth, driven by its continuous investment in research and development (R&D) as well as its commitment to customer-centric solutions. The ongoing demand for animal health products, bolstered by trends in pet ownership and livestock management, presents a robust market opportunity that the company is well-positioned to exploit.

Investors should pay close attention to the insights shared during the fireside chat led by CEO Kristin Peck. Her focus on innovation, customer engagement, and strategic initiatives will likely provide key indicators for Zoetis’s future trajectory. The company's emphasis on integrating advanced technology and scientific expertise into its offerings may continue to differentiate it from competitors, allowing for sustained market share gains.

Moreover, potential advancements in digital solutions and biopharmaceuticals represent significant growth avenues worth monitoring. As regulatory landscapes evolve and the global demand for sustainable and effective animal health solutions increases, Zoetis is poised to play a pivotal role.

In conclusion, while market conditions can be uncertain, Zoetis remains a compelling investment opportunity driven by solid fundamentals, innovative capabilities, and a clear strategic vision. Investors should consider attending the live audio webcast for a comprehensive understanding of the company's future plans and market outlook.